Skip to content

Achieve Life Sciences ACHV Other Income (Expense)

Other Income (Expense) at other companies

Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$2.82M-11.2%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's other income (expense)?
Achieve Life Sciences (ACHV) reported other income (expense) of $295K in Q1 2026.
How has Achieve Life Sciences's other income (expense) changed year-over-year?
Achieve Life Sciences's other income (expense) increased by 340.3% year-over-year, from $67K to $295K.
What is the long-term trend for Achieve Life Sciences's other income (expense)?
Over 4 years (2021 to 2025), Achieve Life Sciences's other income (expense) has grown at a 41.4% compound annual growth rate (CAGR), from -$58K to $232K.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.